This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $299,996 to Flex Orthopaedics, Inc. to conduct late-stage pre-clinical studies on a novel compliant ankle endoprosthesis device. The goal is to demonstrate the device's durability and survivability under physiological loading conditions, in preparation for future clinical testing. This research aims to reinvent treatment options for severe ankle and hindfoot pathologies, providing a viable alternative to ankle-hindfoot fusion or amputation. Successful completion of this 12-month project will generate key data to support an Investigational Device Exemption (IDE) application and a future SBIR Phase II proposal for this innovative prosthetic device.
Generated 1/28/25, 7:33 AM